FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
FURX was delisted on the 1st of July, 2014.
84 hedge funds and large institutions have $261M invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 9 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
19% more call options, than puts
Call options by funds: $6.42M | Put options by funds: $5.39M
7% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 28
1% more capital invested
Capital invested by funds: $258M → $261M (+$3.35M)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
1% less funds holding
Funds holding: 85 → 84 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$12.9M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$8.49M |
| 3 |
RA
Royce & Associates
New York
|
+$7.02M |
| 4 |
Jennison Associates
New York
|
+$6.97M |
| 5 |
Millennium Management
New York
|
+$2.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.66M |
| 3 |
CCM
Consonance Capital Management
New York
|
-$4.64M |
| 4 |
AG
Artal Group
Luxembourg
|
-$4.12M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.45M |
FURX Hedge Fund Activity: Q4 2013 in Review
84 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q4 2013, worth a combined $261M — up 1.3% from $258M a quarter earlier.
Fund positioning in FURX was balanced in Q4 2013: 9 funds opened new positions, 9 closed out, 30 added to existing stakes and 28 trimmed.
The largest buyer was Visium Asset Management, opening a new position worth an estimated $12.9M. The largest seller was BlackRock Fund Advisors, cutting an estimated $4.9M.
- 84 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q4 2013, down from 85 in Q3 2013.
- Funds reported $261M of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q4 2013, up 1.3% quarter-over-quarter.
- 9 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q4 2013 and 9 closed out, a net change of 0 holders.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2013 was Visium Asset Management, an estimated $12.9M added.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q4 2013 was BlackRock Fund Advisors, an estimated $4.9M sold.
Based on aggregated 13F filings for Q4 2013.